Breast Cancer Clinical Trial

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Summary

Following mastectomy (removal of your breast), reconstruction of your breast(s) can be performed using tissue expanders and implants. At the same operation as your mastectomy, a tissue expander is put under the skin and muscles of your chest.

Following your surgery, the tissue expander is gradually filled with salt water over a period of months. Once the expander is filled to the size of your new breast, a second operation is performed. At this time, the tissue expander is removed and a permanent breast implant is placed. This is a standard procedure. We are interested in learning about the use of AlloDerm in breast reconstruction. AlloDerm can be used instead of some of your own chest muscles, in order to cover and protect a tissue expander. We want to know if the use of AlloDerm can decrease your pain or discomfort after surgery and after the filling of your tissue expander.

AlloDerm is made from human tissue. When AlloDerm is made all the cells that could cause your body to reject it are removed. When it is placed in your chest, your own cells will then grow into the AlloDerm, causing it to act like the muscle it is replacing. In this study, you will either have reconstruction with AlloDerm or without AlloDerm.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who undergo immediate, postmastectomy, tissue expander/implant reconstruction
Patients ≥ 21 and ≤ 75 years of age

Exclusion Criteria:

Patient refusal
Patients who will undergo any of the following:
Single-stage implant reconstruction
Combined autogenous tissue expander/implant reconstruction
Patients with a history of prior irradiation
Patients with a history of prior surgery with breast implants
Patients with a history of prior axillary lymph node dissection
Patients who are pregnant

The following eligibility will be confirmed at the time of surgery.

Patients who are deemed intraoperatively by the attending surgeon to have significant mastectomy flap ischemia.
Patients who have an axillary lymph node dissection at the time of mastectomy (Patients undergoing sentinel lymph biopsy are eligible)

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

70

Study ID:

NCT00639106

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

University of Michigan Health System
Ann Arbor Michigan, 48109, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
University of North Carolina School of Medicine
Chapel Hill North Carolina, 27514, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

70

Study ID:

NCT00639106

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider